Malignant pancreatic carcinoid tumour

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Pancreatic carcinoid tumours are rare, particularly within the paediatric population. The clinical presentation is largely dependent on the functionality of the tumour. Although the tumour is generally slow-growing, surgical resection is still the mainstay of curative treatment. Morbidity is, however, significantly contributed by secretion of excess hormones; in view of this, biotherapy is an important treatment strategy. Octreotide, a somatostatin analogue, has been shown to be successful in both symptomatic control and stability of tumour progression. We report a 12-year-old girl, who presented with hypertensive crisis, and showed good response to a combination of chemotherapy and octreotide.

Original languageEnglish
JournalSingapore Medical Journal
Volume48
Issue number12
Publication statusPublished - Dec 2007

Fingerprint

Carcinoid Tumor
Octreotide
Neoplasms
Biological Therapy
Somatostatin
Combination Drug Therapy
Hormones
Pediatrics
Morbidity
Therapeutics
Population

Keywords

  • Carcinoid tumours
  • Paediatric neoplasm
  • Pancreatic carcinoid tumour

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Malignant pancreatic carcinoid tumour. / Abdul Latiff, Zarina; Alias, Hamidah; Syed Zakaria, Syed Zulkifli; Zulfiqar, M. A.; A. Jamal, A. Rahman.

In: Singapore Medical Journal, Vol. 48, No. 12, 12.2007.

Research output: Contribution to journalArticle

@article{5d3cf201179847da8267d41f707ce4ed,
title = "Malignant pancreatic carcinoid tumour",
abstract = "Pancreatic carcinoid tumours are rare, particularly within the paediatric population. The clinical presentation is largely dependent on the functionality of the tumour. Although the tumour is generally slow-growing, surgical resection is still the mainstay of curative treatment. Morbidity is, however, significantly contributed by secretion of excess hormones; in view of this, biotherapy is an important treatment strategy. Octreotide, a somatostatin analogue, has been shown to be successful in both symptomatic control and stability of tumour progression. We report a 12-year-old girl, who presented with hypertensive crisis, and showed good response to a combination of chemotherapy and octreotide.",
keywords = "Carcinoid tumours, Paediatric neoplasm, Pancreatic carcinoid tumour",
author = "{Abdul Latiff}, Zarina and Hamidah Alias and {Syed Zakaria}, {Syed Zulkifli} and Zulfiqar, {M. A.} and {A. Jamal}, {A. Rahman}",
year = "2007",
month = "12",
language = "English",
volume = "48",
journal = "Singapore Medical Journal",
issn = "0037-5675",
publisher = "Singapore Medical Association",
number = "12",

}

TY - JOUR

T1 - Malignant pancreatic carcinoid tumour

AU - Abdul Latiff, Zarina

AU - Alias, Hamidah

AU - Syed Zakaria, Syed Zulkifli

AU - Zulfiqar, M. A.

AU - A. Jamal, A. Rahman

PY - 2007/12

Y1 - 2007/12

N2 - Pancreatic carcinoid tumours are rare, particularly within the paediatric population. The clinical presentation is largely dependent on the functionality of the tumour. Although the tumour is generally slow-growing, surgical resection is still the mainstay of curative treatment. Morbidity is, however, significantly contributed by secretion of excess hormones; in view of this, biotherapy is an important treatment strategy. Octreotide, a somatostatin analogue, has been shown to be successful in both symptomatic control and stability of tumour progression. We report a 12-year-old girl, who presented with hypertensive crisis, and showed good response to a combination of chemotherapy and octreotide.

AB - Pancreatic carcinoid tumours are rare, particularly within the paediatric population. The clinical presentation is largely dependent on the functionality of the tumour. Although the tumour is generally slow-growing, surgical resection is still the mainstay of curative treatment. Morbidity is, however, significantly contributed by secretion of excess hormones; in view of this, biotherapy is an important treatment strategy. Octreotide, a somatostatin analogue, has been shown to be successful in both symptomatic control and stability of tumour progression. We report a 12-year-old girl, who presented with hypertensive crisis, and showed good response to a combination of chemotherapy and octreotide.

KW - Carcinoid tumours

KW - Paediatric neoplasm

KW - Pancreatic carcinoid tumour

UR - http://www.scopus.com/inward/record.url?scp=38449106056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449106056&partnerID=8YFLogxK

M3 - Article

C2 - 18043827

AN - SCOPUS:38449106056

VL - 48

JO - Singapore Medical Journal

JF - Singapore Medical Journal

SN - 0037-5675

IS - 12

ER -